M&A Deal Summary

Telix Pharmaceuticals Acquires QSAM Biosciences

On February 8, 2024, Telix Pharmaceuticals acquired renewable energy company QSAM Biosciences

Acquisition Highlights
  • This is Telix Pharmaceuticals’ 1st transaction in the Renewable Energy sector.
  • This is Telix Pharmaceuticals’ 2nd transaction in the United States.
  • This is Telix Pharmaceuticals’ 1st transaction in Texas.

M&A Deal Summary
Date 2024-02-08
Target QSAM Biosciences
Sector Renewable Energy
Buyer(s) Telix Pharmaceuticals
Deal Type Add-on Acquisition

Target

QSAM Biosciences

Austin, Texas, United States
QSAM Biosciences is a provider of waste management services for small-scale waste water treatment plants and other producers of methane and organic waste. Its current pilot staged combined heat and power (CHP) technology can be deployed with minimal time and expense at thousands of small-scale facilities that must dispose of waste such as methane, biogas and other used fuels at increasingly greater costs and regulatory burdens. QSAM Biosciences was founded in 2004 and is based in Austin, Texas.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Telix Pharmaceuticals

North Melbourne, Australia
Category Company
Sector Life Science
DESCRIPTION

Telix Pharmaceuticals Ltd. is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer.

DEAL STATS #
Overall 3 of 5
Sector (Renewable Energy) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (Texas) 1 of 2
Country (United States) 2 of 3
Year (2024) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-14 Optimal Tracers

Sacramento, California, United States

Optimal Tracers is a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. Optimal Tracers is based in Sacramento, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-27 IsoTherapeutics

Angleton, Texas, United States

IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract manufacturing services. IsoTherapeutics was founded in 2005 and is based in Angleton, Texas.

Buy -
Mergr

Product

Company

Legal